Actively Recruiting

Age: 1Month - 21Years
All Genders
NCT03222375

SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

Led by American Federation of Medical Synergetics · Updated on 2017-11-28

80

Participants Needed

2

Research Sites

531 weeks

Total Duration

On this page

Sponsors

A

American Federation of Medical Synergetics

Lead Sponsor

C

Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS

Collaborating Sponsor

AI-Summary

What this Trial Is About

Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the transitions of subsystems from one autowave regime to another Autowave interaction (of Complex Coherent Action). Autowave interaction is a process associated with the evolution and interaction of spatial and wave structures in the active media of the organism. Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media of physiological systems is more optimal for their vital functions than periodic one. Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and easier in case of change of environmental conditions, i.e. the so called adaptive control is more easily implemented in them. Secondly, "spreading" of oscillations strength along comparatively wide frequency band takes place in chaotic regime. When an organism is young and healthy, physiological systems show the elements of chaotic behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics of health. Decrease in changeability and appearance of stable periodicity of Autowave reverberator are often connected with Autism. The main purpose is to study brain plasticity (the changes that occur in the brain through Autowave reverberator) in children with autism. Research suggests that during development, the brains of children may change in response to their Autowave reverberator differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this study, the investigators will be examining the effects of non-invasive neuromodulation SQUED™ series 28.1 home-use for Treatment of Autowave reverberator of Autism. Integrative Team World Organization of Medical Synergetics (WOMS) - collaborations between physicians and researchers with expertise in biostatistics, physics, mathematics, engineering, and computer science.

CONDITIONS

Official Title

SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

Who Can Participate

Age: 1Month - 21Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of autism or related conditions
  • History of late complications from natal trauma including brain injury, vertebral injury, or cerebral anoxia
  • Identified language deficits and/or other cognitive or behavioral impairments
  • Ability to perform age-appropriate research tasks: infant (1 month to 2 years), child (2 to 12 years), adolescent (12 to 21 years)
  • Presence on the skin of interruption of Autowave front or Autowave reverberators confirmed by photo or graphics
  • Adherence to clinical protocol CRF-SQUED1 including diagnostics, mathematical modeling, and recording of treatment codes
  • Availability of magnetogram and geographic coordinates of home-use area
Not Eligible

You will not qualify if you...

  • Peripheral blindness preventing use of Image converter SQUED1 (iSQUED1)
  • Peripheral deafness preventing use of Sound converter SQUED1 (sSQUED1)
  • Presence of any implanted metal device preventing use of Electromagnetic converter SQUED1 (eSQUED1)
  • Presence of any implanted cardiac pacemaker preventing use of Electromagnetic converter SQUED1 (eSQUED1)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS

Louisville, Kentucky, United States, 40228

Actively Recruiting

2

Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics

Lviv, Solonka Village, Urozayna Street 41, Ukraine, 81131

Actively Recruiting

Loading map...

Research Team

Y

Yuliya Yaroshuk, M.D.s. Ph.D.

CONTACT

Y

Yuriy Fihol, M.D.s. Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here